World’s leading lung cancer organization to confront lung cancer in Latin America through research, education and collaboration.
By 2030, the number of deaths attributed to lung cancer is expected to double for Latin American women and increase by 50% for men.[i] Early detection and molecular testing programs are also not widely available in the region, allowing many treatable cases of lung cancer to go undetected. In order to help confront these and other challenges, the International Association for the Study of Lung Cancer (IASLC) will return to Latin America in August to host a multidisciplinary conference covering all aspects of thoracic cancers.
What: The IASLC Latin America Conference on Lung Cancer 2018 (LACLC 2018) is a four-day meeting that will provide comprehensive education on the detection, treatment and management of thoracic malignancies. There will be educational sessions offered on early detection, smoking cessation, immunotherapy, surgical innovation, targeted therapies, nursing and patient advocacy.
Where and When: Sheraton Hotel, Duarte Quirós 1300, 5000 Córdoba, Argentina | August 15-18, 2018.
Who: Physicians, surgeons, medical oncologists, pulmonologists, radiation oncologists, scientists, basic researchers, patient advocates, nurses, caregivers, survivors and anyone interested in any aspect of thoracic oncology are strongly encouraged to attend this event. The participation of all members of the lung cancer community is critical to fostering valuable exchange and meaningful progress.
Credentialed members of the local, regional and international media are invited to register for the event free of charge.
Why: As a global organization, the IASLC providesmultidisciplinary educational opportunities, disseminates top-tier science and acts as a catalyst for productive dialogue and collaboration throughout the world. Lung cancer is a leading cause of cancer death throughout Latin America for both males and females. The region also faces a lack of access to new medications and a lack of cancer funding in general, with Latin America countries only investing $7-$8 per cancer patient compared with the United States’ $460. With its impending meeting in Latin America, the IASLC hopes to draw attention to these systemic challenges, while also providing outstanding educational opportunities for participants from a wide variety of fields, educational backgrounds and interests.
Some of the conference’s unique features include:
- Sessions specifically geared towards young investigators;
- 12 round table sessions, each focusing on a different specialty;
- A pathology workshop;
- The IASLC School of Thoracic Oncology;
- A cancer and tobacco control program; and many more.
The IASLC Latin America Conference on Lung Cancer 2018 is an event made possible by the collaborative efforts of global experts from Latin America, the United States and Europe. These experts have worked closely with local doctors from nine Latin American countries to produce a conference program that is comprehensive, multidisciplinary and relevant to both local and global audiences.
Interviews with members of the organizing committee can be arranged by contacting Augusto Basbus.
About the IASLC
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 7,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit http://www.iaslc.org for more information.
Follow the IASLC on Facebook, Twitter, Instagram and LinkedIn. For social media updates on conference-related activities, please utilize the official conference hashtag: #LACLC18.
[i] Lopes, Gilberto, Jr. "Lung Cancer in Latin America Revisited: From Panama to Argentina."ASCO, https://am.asco.org/lung-cancer-latin-america-revisited-panama-argentinal. Accessed 9 July 2018.